TY - JOUR
T1 - Barriers of Acceptance to Hospice Care
T2 - a Randomized Vignette-Based Experiment
AU - Trandel, Elizabeth T.
AU - Lowers, Jane
AU - Bannon, Megan E.
AU - Moreines, Laura T.
AU - Dellon, Elisabeth P.
AU - White, Patrick
AU - Cross, Sarah H.
AU - Quest, Tammie E.
AU - Lagnese, Keith
AU - Krishnamurti, Tamar
AU - Arnold, Robert M.
AU - Harrison, Krista L.
AU - Patzer, Rachel E.
AU - Wang, Li
AU - Zarrabi, Ali John
AU - Kavalieratos, Dio
N1 - Publisher Copyright:
© 2022, The Author(s) under exclusive licence to Society of General Internal Medicine.
PY - 2023/2
Y1 - 2023/2
N2 - Background: The per diem financial structure of hospice care may lead agencies to consider patient-level factors when weighing admissions. Objective: To investigate if treatment cost, disease complexity, and diagnosis are associated with hospice willingness to accept patients. Design: In this 2019 online survey study, individuals involved in hospice admissions decisions were randomized to view one of six hypothetical patient vignettes: “high-cost, high-complexity,” “low-cost, high-complexity,” and “low-cost, low-complexity” within two diseases: heart failure and cystic fibrosis. Vignettes included demographics, prognoses, goals, and medications with costs. Respondents indicated their perceived likelihood of acceptance to their hospice; if likelihood was <100%, respondents were asked the barriers to acceptance. We used bivariate tests to examine associations between demographic, clinical, and organizational factors and likelihood of acceptance. Participants: Individuals involved in hospice admissions decisions Main Measures: Likelihood of acceptance to hospice care Key Results: N=495 (76% female, 53% age 45–64). Likelihoods of acceptance in cystic fibrosis were 79.8% (high-cost, high-complexity), 92.4% (low-cost, high-complexity), and 91.5% (low-cost, low-complexity), and in heart failure were 65.9% (high-cost, high-complexity), 87.3% (low-cost, high-complexity), and 96.6% (low-cost, low-complexity). For both heart failure and cystic fibrosis, respondents were less likely to accept the high-cost, high-complexity patient than the low-cost, high-complexity patient (65.9% vs. 87.3%, 79.8% vs. 92.4%, both p<0.001). For heart failure, respondents were less likely to accept the low-cost, high-complexity patient than the low-cost, low-complexity patient (87.3% vs. 96.6%, p=0.004). Treatment cost was the most common barrier for 5 of 6 vignettes. Conclusions: This study suggests that patients receiving expensive and/or complex treatments for palliation may have difficulty accessing hospice.
AB - Background: The per diem financial structure of hospice care may lead agencies to consider patient-level factors when weighing admissions. Objective: To investigate if treatment cost, disease complexity, and diagnosis are associated with hospice willingness to accept patients. Design: In this 2019 online survey study, individuals involved in hospice admissions decisions were randomized to view one of six hypothetical patient vignettes: “high-cost, high-complexity,” “low-cost, high-complexity,” and “low-cost, low-complexity” within two diseases: heart failure and cystic fibrosis. Vignettes included demographics, prognoses, goals, and medications with costs. Respondents indicated their perceived likelihood of acceptance to their hospice; if likelihood was <100%, respondents were asked the barriers to acceptance. We used bivariate tests to examine associations between demographic, clinical, and organizational factors and likelihood of acceptance. Participants: Individuals involved in hospice admissions decisions Main Measures: Likelihood of acceptance to hospice care Key Results: N=495 (76% female, 53% age 45–64). Likelihoods of acceptance in cystic fibrosis were 79.8% (high-cost, high-complexity), 92.4% (low-cost, high-complexity), and 91.5% (low-cost, low-complexity), and in heart failure were 65.9% (high-cost, high-complexity), 87.3% (low-cost, high-complexity), and 96.6% (low-cost, low-complexity). For both heart failure and cystic fibrosis, respondents were less likely to accept the high-cost, high-complexity patient than the low-cost, high-complexity patient (65.9% vs. 87.3%, 79.8% vs. 92.4%, both p<0.001). For heart failure, respondents were less likely to accept the low-cost, high-complexity patient than the low-cost, low-complexity patient (87.3% vs. 96.6%, p=0.004). Treatment cost was the most common barrier for 5 of 6 vignettes. Conclusions: This study suggests that patients receiving expensive and/or complex treatments for palliation may have difficulty accessing hospice.
UR - http://www.scopus.com/inward/record.url?scp=85126899508&partnerID=8YFLogxK
U2 - 10.1007/s11606-022-07468-7
DO - 10.1007/s11606-022-07468-7
M3 - Article
C2 - 35319086
AN - SCOPUS:85126899508
SN - 0884-8734
VL - 38
SP - 277
EP - 284
JO - Journal of general internal medicine
JF - Journal of general internal medicine
IS - 2
ER -